Key Insights

Highlights

Treatment Research

1 treatments under study, led by Mt027 Cart Cells

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06912152Phase 1RecruitingPrimary

MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors

Showing all 1 trials

Research Network

Common Treatments

  • Mt027 Cart Cells1

Active Sponsors

  • Zhejiang University1

Top Investigators

  • Weijia fang1

    First Affiliated Hospital of Zhejiang University

Activity Timeline